Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.54 Billion CNY | 16.35% |
| 2022 | 4.68 Billion CNY | -6.58% |
| 2021 | 5.02 Billion CNY | -30.98% |
| 2020 | 7.37 Billion CNY | 10.42% |
| 2019 | 6.68 Billion CNY | 35.89% |
| 2018 | 4.88 Billion CNY | 20.36% |
| 2017 | 4.06 Billion CNY | 24.91% |
| 2016 | 3.27 Billion CNY | 16.65% |
| 2015 | 2.63 Billion CNY | 38.49% |
| 2014 | 1.9 Billion CNY | 22.01% |
| 2013 | 1.59 Billion CNY | 15.53% |
| 2012 | 1.47 Billion CNY | 16.08% |
| 2011 | 1.16 Billion CNY | 29.85% |
| 2010 | 931.33 Million CNY | 46.81% |
| 2009 | 844.96 Million CNY | -29.66% |
| 2008 | 706.82 Million CNY | 146.68% |
| 2007 | 449.84 Million CNY | 6.38% |
| 2006 | 350.88 Million CNY | 25.19% |
| 2005 | 280.28 Million CNY | 21.43% |
| 2004 | 230.81 Million CNY | 11.4% |
| 2003 | 207.2 Million CNY | 42.38% |
| 2002 | 145.52 Million CNY | 13.94% |
| 2001 | 127.71 Million CNY | 22.49% |
| 2000 | 104.2 Million CNY | 26.51% |
| 1999 | 82.1 Million CNY | 41.91% |
| 1998 | 57.66 Million CNY | 38.22% |
| 1997 | 41.65 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.49 Billion CNY | 55.35% |
| 2024 Q3 | 1.33 Billion CNY | -46.58% |
| 2024 Q2 | 2.23 Billion CNY | 45.73% |
| 2023 Q1 | 1.32 Billion CNY | 116.0% |
| 2023 Q4 | 953.93 Million CNY | -28.52% |
| 2023 Q2 | 1.2 Billion CNY | -9.08% |
| 2023 Q3 | 1.33 Billion CNY | 10.79% |
| 2023 FY | - CNY | 16.35% |
| 2022 Q2 | 987.21 Million CNY | -29.08% |
| 2022 Q1 | 1.39 Billion CNY | 678.91% |
| 2022 Q4 | 613.38 Million CNY | -47.85% |
| 2022 FY | - CNY | -6.58% |
| 2022 Q3 | 1.17 Billion CNY | 19.14% |
| 2021 Q3 | 1.58 Billion CNY | 6.67% |
| 2021 Q2 | 1.49 Billion CNY | -13.44% |
| 2021 FY | - CNY | -30.98% |
| 2021 Q1 | 1.72 Billion CNY | -19.03% |
| 2021 Q4 | -240.47 Million CNY | -115.13% |
| 2020 FY | - CNY | 10.42% |
| 2020 Q1 | 1.53 Billion CNY | -19.32% |
| 2020 Q2 | 1.65 Billion CNY | 7.8% |
| 2020 Q3 | 1.83 Billion CNY | 10.76% |
| 2020 Q4 | 2.12 Billion CNY | 15.88% |
| 2019 Q1 | 1.36 Billion CNY | 8.81% |
| 2019 FY | - CNY | 35.89% |
| 2019 Q2 | 1.46 Billion CNY | 7.34% |
| 2019 Q3 | 1.47 Billion CNY | 0.4% |
| 2019 Q4 | 1.9 Billion CNY | 29.23% |
| 2018 Q2 | 1.08 Billion CNY | 1.73% |
| 2018 Q3 | 1.11 Billion CNY | 2.7% |
| 2018 FY | - CNY | 20.36% |
| 2018 Q1 | 1.06 Billion CNY | 2.48% |
| 2018 Q4 | 1.25 Billion CNY | 12.64% |
| 2017 Q3 | 900.52 Million CNY | 2.64% |
| 2017 Q1 | 939.36 Million CNY | 11.28% |
| 2017 Q4 | 1.04 Billion CNY | 15.73% |
| 2017 Q2 | 877.34 Million CNY | -6.6% |
| 2017 FY | - CNY | 24.91% |
| 2016 Q4 | 844.17 Million CNY | 22.61% |
| 2016 Q1 | 781.09 Million CNY | 4.03% |
| 2016 Q3 | 688.48 Million CNY | -1.09% |
| 2016 FY | - CNY | 16.65% |
| 2016 Q2 | 696.05 Million CNY | -10.89% |
| 2015 Q1 | 656 Million CNY | 31.68% |
| 2015 Q4 | 750.86 Million CNY | 31.7% |
| 2015 Q3 | 570.14 Million CNY | -4.73% |
| 2015 Q2 | 598.46 Million CNY | -8.77% |
| 2015 FY | - CNY | 38.49% |
| 2014 Q1 | 466.44 Million CNY | 33.93% |
| 2014 FY | - CNY | 22.01% |
| 2014 Q4 | 498.19 Million CNY | 18.75% |
| 2014 Q3 | 419.51 Million CNY | -0.78% |
| 2014 Q2 | 422.79 Million CNY | -9.36% |
| 2013 Q3 | 340.06 Million CNY | -11.63% |
| 2013 Q2 | 384.8 Million CNY | -6.58% |
| 2013 FY | - CNY | 15.53% |
| 2013 Q1 | 411.89 Million CNY | 5.49% |
| 2013 Q4 | 348.28 Million CNY | 2.42% |
| 2012 Q4 | 390.45 Million CNY | 116.2% |
| 2012 Q1 | 384.71 Million CNY | 70.99% |
| 2012 Q2 | 360.62 Million CNY | -6.26% |
| 2012 Q3 | 180.6 Million CNY | -49.92% |
| 2012 FY | - CNY | 16.08% |
| 2011 Q3 | 269.75 Million CNY | -2.39% |
| 2011 Q4 | 224.99 Million CNY | -16.59% |
| 2011 Q2 | 276.35 Million CNY | -13.22% |
| 2011 FY | - CNY | 29.85% |
| 2011 Q1 | 318.45 Million CNY | 117.34% |
| 2010 Q4 | 146.52 Million CNY | -36.07% |
| 2010 Q1 | 255.59 Million CNY | 82.85% |
| 2010 Q2 | 248.22 Million CNY | -2.88% |
| 2010 Q3 | 229.18 Million CNY | -7.67% |
| 2010 FY | - CNY | 46.81% |
| 2009 Q4 | 139.78 Million CNY | -5.62% |
| 2009 FY | - CNY | -29.66% |
| 2009 Q2 | 127.84 Million CNY | -23.75% |
| 2009 Q1 | 167.66 Million CNY | -34.44% |
| 2009 Q3 | 148.1 Million CNY | 15.84% |
| 2008 Q4 | 255.74 Million CNY | 64.67% |
| 2008 Q3 | 155.3 Million CNY | -8.49% |
| 2008 Q2 | 169.72 Million CNY | -39.34% |
| 2008 Q1 | 279.78 Million CNY | 3584.66% |
| 2008 FY | - CNY | 146.68% |
| 2007 Q2 | 85.59 Million CNY | -29.4% |
| 2007 Q4 | -8.02 Million CNY | -105.58% |
| 2007 Q3 | 143.94 Million CNY | 68.17% |
| 2007 Q1 | 121.23 Million CNY | 21.07% |
| 2007 FY | - CNY | 6.38% |
| 2006 Q2 | 79.1 Million CNY | -12.13% |
| 2006 Q1 | 90.02 Million CNY | 19.69% |
| 2006 Q4 | 100.13 Million CNY | 18.96% |
| 2006 FY | - CNY | 25.19% |
| 2006 Q3 | 84.17 Million CNY | 6.41% |
| 2005 Q1 | 71.88 Million CNY | -5.45% |
| 2005 Q2 | 73.19 Million CNY | 1.81% |
| 2005 Q3 | 68.82 Million CNY | -5.96% |
| 2005 Q4 | 75.21 Million CNY | 9.28% |
| 2005 FY | - CNY | 21.43% |
| 2004 Q2 | 32 Million CNY | -42.5% |
| 2004 FY | - CNY | 11.4% |
| 2004 Q4 | 76.03 Million CNY | 33.4% |
| 2004 Q1 | 55.65 Million CNY | -12.04% |
| 2004 Q3 | 56.99 Million CNY | 78.1% |
| 2003 Q1 | 46.74 Million CNY | 74.07% |
| 2003 Q3 | 54.01 Million CNY | 19.73% |
| 2003 FY | - CNY | 42.38% |
| 2003 Q4 | 63.27 Million CNY | 17.14% |
| 2003 Q2 | 45.11 Million CNY | -3.48% |
| 2002 Q4 | 26.85 Million CNY | 7.17% |
| 2002 Q2 | 48.61 Million CNY | 115.48% |
| 2002 Q1 | 22.56 Million CNY | 0.0% |
| 2002 FY | - CNY | 13.94% |
| 2002 Q3 | 25.05 Million CNY | -48.46% |
| 2001 FY | - CNY | 22.49% |
| 2000 FY | - CNY | 26.51% |
| 1999 FY | - CNY | 41.91% |
| 1998 FY | - CNY | 38.22% |
| 1997 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | -54.949% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | -390.978% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | -2774.467% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 1186.862% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 39361.291% |
| NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | -242.142% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | -3407.944% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | -255.851% |